ArticleBMJ open2024

Safety of high-dose amikacin in the first week of all-oral rifampicin-resistant tuberculosis treatment for the prevention of acquired resistance (STAKE): protocol for a single-arm clinical trial.

Jihad Snobre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.